Overview

Barine Majewska is counsel in Vicente Sederberg's Denver office, where she is a leading member of the firm's Entheogens and Emerging Therapies Practice Group. She became an attorney because she loved the logical reasoning skills required by law, and grew to enjoy applying those skills to help people and companies be successful in business. After graduating from the University of Virginia School of Law, she joined the corporate department at Cooley LLP, where she worked with technology and startup companies doing venture capital, M&A, and technology licensing work.

Later in her legal career, her long-standing respect for psychedelics and plant medicine work led her to consider going back to school for a PhD in clinical psychology to work in a clinical setting. She was offered a fantastic opportunity to intern in psilocybin studies at the Johns Hopkins School of Medicine, where her firsthand experience working as both a research assistant and guide in psilocybin sessions gave her clear insights into the potency, benefits, and pitfalls of psychedelic work.

In 2016, Barine returned to law and joined VS. She was recently appointed to a leadership role in VS’s Enthogens and Emerging Therapies Practice Group. In this role, Barine applies VS’s pioneering spirit in the cannabis industry to fostering the effective, safe and legal use of psilocybin, ketamine, MDMA and other entheogens. She is fascinated by the ethical, cultural, spiritual, psychological, and commercial challenges and opportunities presented by this emerging industry. In addition to her work in the psychedelic space, she assists clients with corporate and intellectual property licensing matters, and loves working with driven, innovative clients.

She has deep interests in meditation, biohacking and the many types of altered states of consciousness accessed throughout human history via different technologies. She holds an undergraduate degree in physics, and is fluent in Turkish.

Events

• Speaker, Cannalaw Summit, "Quickfire Questions: What's next for hemp, recreational, medical, pharma, and psychedelics?,” Online, May 06, 2021